Folotyn
Payments companies reported to CMS as associated with Folotyn. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Folotyn, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Folotyn
These are the largest totals companies reported as associated with Folotyn. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Elizabeth Brem | Orange, CA | Hematology & Oncology | $124.35 |
| Makena Turner | Spokane, WA | Physician Assistant | $20.15 |
| Mirela Andrei | Spokane, WA | Medical Oncology | $20.15 |
| Arvind Chaudhry | Spokane, WA | Hematology & Oncology | $20.15 |
| Mackenzi Heaton | Spokane, WA | Nurse Practitioner | $20.15 |
| Atul Butala | Utica, NY | Hematology & Oncology | $18.23 |
| Muhammad Akhtar | East Providence, RI | Hematology & Oncology | $16.90 |
| Omar Meer | East Providence, RI | Internal Medicine | $16.90 |
Prescribed Folotyn?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.